Status:
COMPLETED
Maternal-foetal Transmission of SARS-Cov-2
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Collaborating Sponsors:
Centre de Biophysique Moléculaire - Pr Chantal Pichon
Professeur TOUMI Hechmi
Conditions:
Maternal Fetal Infection Transmission
COVID-19
Eligibility:
FEMALE
18-48 years
Brief Summary
One case of maternal-fetal transmission of SARS Cov-2 was published (1). Ig M and Ig G were found at two hours after birth of a new born from a mother COVID-19. Another study on few newborns COVID-19 ...
Detailed Description
Pregnant women SARS cov-2 positives during pregnancy or during labor tested by a RT-PCR SARS-Cov-2 on nasopharyngeal swabs and/or by serologies. After informed consent the ivestigators will proceed d...
Eligibility Criteria
Inclusion
- All pregnant women SARS-Cov-2 positive during the pregnancy
- Informed consent obtained
- 18 years to 48 years
Exclusion
- Pregnant women without SARS-Cov-2 infection ( PCR test and or serologies negatives)
- curatorship patients.
- Refusal to participate to the study
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 4 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04395924
Start Date
May 5 2020
End Date
May 4 2021
Last Update
June 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Orléans
Orléans, France